CASI Pharmaceuticals CASIF
OTC CASIF
$0.12 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

CASI Pharmaceuticals (CASIF) Return on Equity [ROE] (2023 - 2024)

Updated

CASI Pharmaceuticals (CASIF) posted Return on Equity [ROE] of -214.06% for Q2 2024, down 93.00 percentage points from -121.06% a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Return on Equity [ROE] (2023 - 2024) Analysis & Trends

For FY2022, CASI Pharmaceuticals' Return on Equity [ROE] came in at -69.37%, down 28.58 percentage points from FY2021.

  • In prior years, CASI Pharmaceuticals' Return on Equity [ROE] was -40.79% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 CASI Pharmaceuticals 2.47 Mn -18.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -214.06%
Sep 30, 2023 -130.94%
Jun 30, 2023 -121.06%
Mar 31, 2023 -100.41%
API Access

CASI Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CASIF&period=max&api_key=YOUR_API_KEY